Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Windtree Therapeutics, Inc is a biotechnology business based in the US. Windtree Therapeutics shares (WINT) are listed on the NASDAQ and all prices are listed in US Dollars. Windtree Therapeutics employs 31 staff and has a market cap (total outstanding shares value) of USD$105.1 million.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Mobile users
Latest market close | USD$5.94 |
---|---|
52-week range | USD$3.05 - USD$44.91 |
50-day moving average | USD$6.6368 |
200-day moving average | USD$7.138 |
Wall St. target price | USD$12.13 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$-2.134 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.94 from 2020-12-09
1 week (2021-01-12) | N/A |
---|---|
1 month (2020-12-23) | 12.29% |
3 months (2020-10-19) | N/A |
6 months (2020-07-19) | N/A |
1 year (2020-01-19) | N/A |
---|---|
2 years (2019-01-19) | N/A |
3 years (2018-01-19) | N/A |
5 years (2016-01-19) | N/A |
Gross profit TTM | USD$-12,489,000 |
---|---|
Return on assets TTM | -15.41% |
Return on equity TTM | -50.45% |
Profit margin | 0% |
Book value | $4.475 |
Market capitalisation | USD$105.1 million |
TTM: trailing 12 months
There are currently 119,333 Windtree Therapeutics shares held short by investors – that's known as Windtree Therapeutics's "short interest". This figure is 21.8% down from 152,579 last month.
There are a few different ways that this level of interest in shorting Windtree Therapeutics shares can be evaluated.
Windtree Therapeutics's "short interest ratio" (SIR) is the quantity of Windtree Therapeutics shares currently shorted divided by the average quantity of Windtree Therapeutics shares traded daily (recently around 15067.297979798). Windtree Therapeutics's SIR currently stands at 7.92. In other words for every 100,000 Windtree Therapeutics shares traded daily on the market, roughly 7920 shares are currently held short.
However Windtree Therapeutics's short interest can also be evaluated against the total number of Windtree Therapeutics shares, or, against the total number of tradable Windtree Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Windtree Therapeutics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Windtree Therapeutics shares in existence, roughly 10 shares are currently held short) or 0.0165% of the tradable shares (for every 100,000 tradable Windtree Therapeutics shares, roughly 17 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Windtree Therapeutics.
Find out more about how you can short Windtree Therapeutics stock.
We're not expecting Windtree Therapeutics to pay a dividend over the next 12 months.
Windtree Therapeutics's shares were split on a 1:3 basis on 29 April 2020. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Windtree Therapeutics shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Windtree Therapeutics shares which in turn could have impacted Windtree Therapeutics's share price.
Over the last 12 months, Windtree Therapeutics's shares have ranged in value from as little as $3.05 up to $44.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Windtree Therapeutics's is 0.1122. This would suggest that Windtree Therapeutics's shares are less volatile than average (for this exchange).
Windtree Therapeutics, Inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. Its four lead development programs include istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as in Phase 2a clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase 2b clinical trial to treat respiratory distress syndrome (RDS) in premature infants; lyophilized KL4 surfactant for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase 2b clinical trial for the treatment of genetically associated hypertension. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania.
Steps to owning and managing SSNC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing SMED, with 24-hour and historical pricing before you buy.
Steps to owning and managing SJW, with 24-hour and historical pricing before you buy.
Steps to owning and managing SFBS, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEDS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SC, with 24-hour and historical pricing before you buy.
Steps to owning and managing RTW, with 24-hour and historical pricing before you buy.
Steps to owning and managing RIVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing RVSB, with 24-hour and historical pricing before you buy.